Vazyme(SH:688105) Sou Hu Cai Jing·2025-07-05 22:16Core Viewpoint - The company, Nanjing Novogene Bioinformatics Technology Co., Ltd. (诺唯赞), is planning to repurchase shares worth between 5 million to 10 million RMB as part of its employee stock ownership plan or equity incentive program, with a maximum repurchase price set at 30 RMB per share [1][2]. Group 1: Share Price and Market Capitalization - As of July 4, 2025, the share price of Novogene is 22.75 RMB, reflecting a 3.98% increase from the previous week [1]. - The highest intraday price recorded on July 3, 2025, was 23.09 RMB, while the lowest was 21.76 RMB on June 30, 2025 [1]. - The current total market capitalization of Novogene is 9.048 billion RMB, ranking 29th out of 50 in the biopharmaceutical sector and 1798th out of 5149 in the A-share market [1]. Group 2: Share Repurchase Plan - The share repurchase plan was approved during the 17th meeting of the second board of directors on June 19, 2025, allowing for the repurchase of shares using self-owned funds [2]. - The repurchase period is set from June 19, 2025, to June 18, 2026, with no shares repurchased as of June 30, 2025 [3]. - The company will make repurchase decisions based on market conditions and will fulfill its information disclosure obligations regarding the progress of the share repurchase [3].